Modeling Variability in Cardiac Electrophysiology: A Moment Matching Approach by Tixier, Eliott et al.
1
S1 Supplementary Material for:
Modeling Variability in Cardiac Electrophysiology: A Moment
Matching Approach
Eliott Tixier2,1, Damiano Lombardi1,2, Blanca Rodriguez3, Jean-Frédéric Gerbeau1,2,*
1 Inria Paris, 75012 Paris, France
2 Sorbonne Universités, UPMC Univ Paris 6, UMR 7598 LJLL, 75005 Paris, France




Table 1. Statistics summary of the estimated parameters from the Decker model in control conditions
(no drug block).
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.104 1.100 0.4% 0.155 0.150 3.1%
gK1 1.099 1.100 0.1% 0.164 0.150 9.2%
gto 1.103 1.100 0.3% 0.182 0.150 21.2%
gKr 1.091 1.100 0.9% 0.172 0.150 14.4%
gKs 1.264 1.100 14.9% 0.426 0.150 184.0%
gCaL 1.102 1.100 0.2% 0.177 0.150 17.8%
Table 2. Statistics summary of the estimated parameters from the Decker model in drug block
conditions (90% block for Ito,IKr and ICaL).
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.104 1.100 0.4% 0.158 0.150 5.5%
gK1 1.102 1.100 0.1% 0.154 0.150 2.6%
gKs 1.100 1.100 0.0% 0.158 0.150 5.1%
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Table 3. Statistics summary of the estimated parameters from the Decker model in control conditions
with moments constraints from drug block estimation.
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.104 1.100 0.4% 0.158 0.150 5.5%
gK1 1.102 1.100 0.1% 0.154 0.150 2.6%
gto 1.104 1.100 0.4% 0.182 0.150 21.3%
gKr 1.101 1.100 0.1% 0.173 0.150 15.6%
gKs 1.100 1.100 0.0% 0.158 0.150 5.1%
gCaL 1.102 1.100 0.2% 0.176 0.150 17.1%
Table 4. Statistics summary of the estimated parameters from the Courtemanche model in control
conditions.
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.098 1.100 0.2% 0.149 0.150 0.7%
gK1 1.102 1.100 0.2% 0.163 0.150 9.1%
gto 1.109 1.100 0.8% 0.180 0.150 20.1%
gKr 1.087 1.100 1.0% 0.302 0.150 102%
gKs 1.201 1.100 9.2% 0.426 0.150 184%
gCaL 1.104 1.100 0.4% 0.178 0.150 18.3%
Table 5. Statistics summary of the estimated parameters from the Courtemanche model at 2Hz
pacing frequency.
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.099 1.100 0.1% 0.151 0.150 1.0%
gK1 1.110 1.100 0.9% 0.167 0.150 11.6%
gto 1.109 1.100 0.8% 0.185 0.150 23.3%
gKr 1.064 1.100 3.2% 0.366 0.150 144%
gKs 1.263 1.100 14.9% 0.424 0.150 183%
gCaL 1.132 1.100 2.9% 0.208 0.150 38.4%
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Table 6. Statistics summary of the estimated parameters from the Courtemanche model (combined
1Hz+2Hz data).
Parameter µ µex rel. err. σ σex rel. err.
gNa 1.098 1.100 0.2% 0.149 0.150 0.4%
gK1 1.103 1.100 0.2% 0.166 0.150 11.0%
gto 1.106 1.100 0.6% 0.165 0.150 9.7%
gKr 1.096 1.100 0.4% 0.266 0.150 77.2%
gKs 1.150 1.100 4.6% 0.424 0.150 183%
gCaL 1.102 1.100 0.2% 0.161 0.150 7.4%
Table 7. Davies model: experimental parameter calibration and observable moment matching results.
Conductance
OMM results Reference values
µ σ exp. calibration literature unit
gNa - - 27.4 8.25 nS/pF
gNaL - - 7.26 ×10−2 1.1 ×10−2 nS/pF
gKr 0.96 0.03 4.82 ×10−2 1.39 ×10−2 nS/pF
gKs 1.06 0.12 1.38 ×10−1 7.47 ×10−3 nS/pF
gK1 - - 2.91 ×10−1 5.0 ×10−1 nS/pF
gKp - - 7.93 ×10−3 2.76 ×10−3 nS/pF
gto1 1.03 0.11 0.38 0.18 nS/pF
gCaL - - 2.0 ×10−4 9.7 ×10−4 nS/pF
gbCa - - 5.88 ×10−6 7.98 ×10−7 nS/pF
gpCa - - 9.84 ×10−4 5.75 ×10−2 pA/pF
gClb - - 9.45 ×10−6 2.25 ×10−4 nS/pF
gto2 - - 4.54 ×10−9 4 ×10−7 L/F.ms
gNaCa - - 6.95 ×10−2 5.85 pA/pF
gNaK - - 6.6 ×10−3 6.19 ×10−1 pA/pF
Table 8. Human biomarkers dataset statistics.
group APD90 APD50 APD20 APA RMP dV/dtmax V20
SR
representative (#163) 324 142 5 93 -74 214 -19
median 319 151 5 95 -74 213 -16
mean 317.7 138.7 7.1 94.8 -73.8 219.7 -16.1
std 42.7 44.1 8.2 7.1 3.9 67.9 6.4
AF
representative (#131) 213 105 38 98 -76 237 0
median 213 101 27 102 -77 229 -4
mean 216.4 101.5 30.2 101.6 -76.8 232.0 -4.4
std 34.4 27.7 17.9 7.6 3.6 70.3 10.9
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SR group AF group AF/SR rel. change
gNa 1.17 1.11 -5% 7.8 nS/pF
gK1 0.45 1.45 +220% 9.0 ×10−2 nS/pF
gto 1.12 2.83 × 10−3 -100% 1.65 ×10−1 nS/pF
gKr 1.15 1.41 +23% 2.94 ×10−2 nS/pF
gKs 1.10 1.21 +10% 1.29 ×10−1 nS/pF
gCaL 0.87 0.32 -63% 1.24 ×10−1 nS/pF
gbNa 1.26 1.31 +4% 6.74 ×10−4 nS/pF
gbCa 1.14 1.85 +63% 1.13 ×10−3 nS/pF
gNaK 0.78 0.80 +3% 0.6 pA/pF
gNaCa 4.65 × 10−2 2.01 ×43 1.6 ×103 pA/pF
gKur 0.54 0.21 -60% 1.0 dimensionless
Table 10. Statistics summary of the estimated parameters from the Courtemanche model with
experimental data (SR and AF group), normalized by the reference values.
Group SR AF
Parameter µ σ µ σ
gNa 1.464 0.652 1.310 0.533
gK1 0.431 0.125 1.744 0.656
gto 1.090 0.219 0.310 0.392
gKr 0.934 0.375 1.997 1.314
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Figure 1. L-curve: calibration fitness plotted against the distance to reference conductances.
Influence of K in the calibration step We replicated the calibration procedure in Test Case
4 with the SR group representative several times by varying the regularization parameter K. In
Figure 1, the fitness is plotted against the distance to the reference conductances values for different
values of K. g denotes the conductance values estimated by the CMA-ES algorithm, ĝ are the
reference values for these conductances, u(g) are the simulated biomarkers and û are the experimental
biomarkers to be fitted. We obtain a so-called “L-curve” which is typical of such hyper-parameter
studies. We see that K=5e-3 is a reasonable choice as it is close the curve’s elbow and therefore a
good trade-off between goodness of fit and distance to the reference values.
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Figure 2. Normalized histograms of the experimental biomarkers pairwise products for both SR
(blue) and AF (red) groups. The black solid lines correspond to the PDF of each pairwise product
estimated by the observable moment matching method. Biomarkers computed from an AP. This
figure is an extension of Fig.7(C) in the main article.
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Appendix A: Illustration of the OMMmethod using the Davies
model
We propose to illustrate the OMM approach using a simple test case that highlights its non-parametric
nature. Indeed, the PDF is estimated point-wise in the parameter space and therefore potentially
any distribution may be recovered. We propose to study a test case where one of the parameters has
a uniform distribution and two of them are correlated.
For the synthetic data set, N = 104 APs were generated using the Davies model with three
uncertainparameters: gNa, gKr, gCaL. gKr and gCaL were drawn from a bivariate normal distribution
of mean vector µ = (1, 1) and of covariance matrix:





which means gKr and gCaL have a standard deviation of 0.15 and a Pearson correlation coefficient of
90%. gNa is sampled from an uncorrelated uniform distribution over [0.5, 2.]. The simulation database
was built by sampling the same three parameters over the domain Θ = [0.3, 2.0]3. Nc = 212 samples
were drawn and the number of moments to be matched was set to Nm = 3. The estimated marginals
are shown in Fig. 3. We also plotted the estimated correlation matrix of the three conductances
in Fig. 4. The correlation between gKr and gCaL is captured by the method even though it is
under-estimated at 60% instead of the 90% of the true distribution.
The discrepancy observed between the true and estimated correlation would be not be observed
when using Bayesian inference techniques. This is a limitation of the proposed method. In this
particular case, the observable quantities could be enriched with auto-correlation quantities to be
able to correctly estimate the parameters correlation.







































































Figure 4. Estimated correlation matrix.
